NEW YORK (GenomeWeb News) – Agilent Technologies announced today that it has acquired the nucleic acid medicines business of Dowpharma for an undisclosed sum.
 
The acquisition is concurrent with an expansion of its nucleic acid active pharmaceutical ingredient manufacturing facility in Boulder, Colo. Agilent said that it would add large-scale nucleic acid synthesis, purification, and drying capacity to its capabilities by the end of this year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.